Annie Yoshiyama - 05 Jun 2024 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: SVP, Finance
Signature: /s/Annie Yoshiyama
Issuer symbol: ALLO
Transactions as of: 05 Jun 2024
Net transactions value: $0
Form type: 3
Filing time: 11 Jun 2024, 16:10:19 UTC
Previous filing: 09 Aug 2022
Next filing: 28 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALLO	Common Stock						101,758	05 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALLO	Stock Option (Right to buy)							05 Jun 2024	Common Stock	348,708	$3.98	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting, 1/4th of the RSUs will vest on April 20th, 2025 and the remainder will vest annually thereafter.
F2	25% of the shares subject to the stock option shall vest on April 8, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.